Skip to main content
EnglishEN
European Commission logo print header

Health Innovation Next Generation Payment & Pricing Models

Project description

DEENESFRITPL

New pricing and payment schemes for health innovation

The variety of innovative technologies in healthcare delivery needs several pricing and payment models adapted in their design and implementation. However, the lack of appropriate data infrastructure, legal barriers, and unwillingness to adapt current systems often impede their use. The EU-funded HI-PRIX project will map and formulate new pricing and payment schemes to use across technology classes, therapeutic areas, settings, and healthcare systems/geographies and related principles to guide successful adjustment and flexible implementation. The project will investigate the impact on competitiveness, innovation, equity, and affordability of a pipeline of contracting modalities for health innovations and address the challenges and concerns of payers, manufacturers, healthcare professionals, and patients about different pricing models.

Objective

The variety of innovative technologies with the potential to revolutionize the delivery of health care means that the policy toolbox will need several pricing and payment models, adapted in their design and implementation according to the specific situation. Although there are examples of novel pricing and payment models, the lack of appropriate data infrastructure, legal barriers and unwillingness to adapt current systems often prevent their use. Therefore, the overall objectives of the Health Innovation Next Generation Pricing Models (HI – PRIX) project are: i) to map and formulate new pricing and payment schemes that can be used across technology classes, therapeutic areas, setting and healthcare systems/geographies together with a related set of principles that may guide successful adjustment and flexible implementation to the context of use; ii) to investigate the impact on competitiveness, innovation, equity and affordability of a pipeline of contracting modalities for health innovations; iii) to address the challenges and concerns of payers, manufacturers, healthcare professionals, and patients about different models of pricing by sustaining an effective dialogue across stakeholders’ groups about the trade-offs between affordability, innovation and patient access. Coordinated by Bocconi University, the HI-PRIX Consortium involves 18 partners from 10 European countries, including academic institutions, public authorities, healthcare providers, and independent research organizations. Through theoretical models, quantitative simulation, qualitative research work and case-studies, this three-year project structured around 10 WPs, will generate new evidence on the role of public sector in R&D and indirect medical and environmental costs in pricing and reimbursement determinations, on the pricing dynamics over pharmaceutical products’ lifecycle, on the impact of policies and incentives on the competitiveness, innovativeness and equity in the healthcare system.

Fields of science

Keywords

Programme(s)

Topic(s)

Call for proposal

HORIZON-HLTH-2022-IND-13

See other projects for this call

Funding Scheme

HORIZON-RIA - HORIZON Research and Innovation Actions

Coordinator

UNIVERSITA COMMERCIALE LUIGI BOCCONI
Net EU contribution
€ 1 241 307,50
Address
VIA SARFATTI 25
20136 Milano
Italy

See on map
Region
Nord-Ovest Lombardia Milano
Activity type
Higher or Secondary Education Establishments
Links
Total cost
€ 1 241 307,50

Participants (11)

Partners (6)

Share this page

Download

Last update: 17 November 2022

My Booklet

Permalink: https://cordis.europa.eu/project/id/101095593

European Union, 2024